rethinkMushrooms Search
Menu
Guide

Mycelium on Grain: Why the Supplement Industry Debates It

What mycelium on grain is, why a 2025 study found 33-68% grain starch in real supplements, and how to identify these products on a label.

Fruiting Body vs. Mycelium: The Supplement Debate

33–68% grain starch

A 2025 peer-reviewed analysis of real-world myceliated chaga supplements found alpha-glucan content of 33-68% — grain starch, not mushroom compounds — compared to near-zero starch in authentic chaga canker.

Windsor et al., International Journal of Molecular Sciences, 2025

1–5%

typical beta-glucan content found in grain-grown chaga supplement products (Windsor et al., 2025)

Label loophole

supplement labels say 'polysaccharides' — a number that includes both active beta-glucans and inert grain starch (Timm et al., 2023)

Species matters

Cordyceps militaris is grown on grain to produce actual fruiting bodies, making its grain-substrate products a different category (Liang et al., 2014)

Windsor et al., International Journal of Molecular Sciences, 2025

Mycelium on grain mushroom supplements: what the research shows about alpha-glucan content and the labeling problemView as image ↗

Mycelium on grain is the production method behind a large share of the mushroom supplements sold in the United States. The process involves inoculating a grain substrate with mushroom spawn, allowing the mycelium to colonize partially, then drying and grinding the whole mass, grain included, into a powder. A 2025 peer-reviewed analysis of real-world supplements tested this directly and found alpha-glucan content (grain starch) between 33 and 68% in grain-colonized products, compared to near-zero starch in authentic chaga canker material from the wild.[1] Beta-glucans, the immune-active compounds that define medicinal mushroom efficacy, measured at 1-5% in the same grain-grown products.

That gap is the source of the controversy. This article explains what mycelium on grain is at a process level, what the analytical chemistry data shows about its composition, why the production method persists despite the quality questions, and how researchers identify grain content in commercial supplements. For the broader debate about which supplement form is better overall, the complete guide to the fruiting body vs. mycelium debate covers all sides.

Key Takeaways

  • Mycelium-on-grain production inoculates grain (rice, oats, or wheat) with mushroom spawn, colonizes it partially, then grinds the whole mass into powder without separating the grain
  • A 2025 peer-reviewed study tested real chaga supplement products and found alpha-glucan (grain starch) content of 33-68%, with beta-glucan content at only 1-5% (Windsor et al., 2025)
  • Supplement labels typically report "polysaccharides," a measurement that captures both active beta-glucans and inert alpha-glucan starches together — a labeling gap identified in a 2023 review (Timm et al., 2023)
  • Mass spectrometry analysis of commercial mushroom supplements has detected starch-derived fragments in grain-grown products, providing a chemical fingerprint of the grain content (López-García et al., 2016)
  • Cordyceps militaris is a notable exception: grain substrates are legitimately used to produce Cordyceps fruiting bodies, making grain-based Cordyceps products a distinct category from mycelium-on-grain
  • The grain type used affects mycelial colonization density and rate, with different cereal grains producing different mycelial characteristics at the same inoculation conditions (Nguyen and Ranamukhaarachchi, 2020)

What Mycelium on Grain Actually Is: The Production Process

The phrase "mycelium on grain" describes a substrate colonization method used in mushroom cultivation, adapted for supplement manufacturing.

The production sequence works like this: a grain substrate, most commonly brown rice, oats, wheat berries, or rye, is sterilized to eliminate competing organisms. Mushroom spawn is inoculated into the grain. Over weeks to months, the fungal mycelium, the thread-like vegetative network of the mushroom organism, grows throughout the grain mass and digests parts of the substrate. At the end of the colonization period, the mass is dried and ground into a powder. The final product is a physical mixture of fungal tissue and partially digested grain that cannot be meaningfully separated.

Nguyen and Ranamukhaarachchi, testing how different grain types affect mycelial growth in Pleurotus eryngii and Pleurotus ostreatus, found significant differences in mycelial density and colonization rate depending on the cereal grain used.[4] Rice, wheat, oat, barley, and millet all produced different mycelial characteristics at identical inoculation conditions. This finding has a practical implication for supplement composition: because different grains contain different starch concentrations, and because the ratio of fungal biomass to residual grain varies by grain type and colonization time, the final beta-glucan-to-starch ratio in the powder varies substantially from batch to batch and producer to producer.

The key structural distinction: in mycelium-on-grain products, the mushroom never forms a fruiting body. No cap, no stem, none of the reproductive structures associated with the organism's mature life stage. The mycelial network colonizes the grain matrix but remains in the vegetative phase throughout. This matters for compound profile because many of the secondary metabolites concentrated in fruiting bodies, including the triterpenoids in reishi and specific polysaccharide structures in turkey tail, are synthesized during or after the fruiting body formation process.

The alternative production pathway, liquid-fermented mycelium, grows the mycelium in a liquid medium rather than on grain. This allows the fungal biomass to be separated from the growth substrate by filtration. Liquid-fermented mycelium products are a genuinely different category from mycelium-on-grain products. The controversy in the supplement industry primarily concerns grain-based solid-state cultivation, not liquid-fermented systems.

The 2025 Lab Data: What Real Supplements Actually Contain

For years, the criticisms of mycelium-on-grain products rested largely on theoretical arguments about compound profiles and production methods. Windsor and colleagues changed that with a 2025 analytical study that measured the actual composition of real-world supplements on the market.

Testing a range of chaga (Inonotus obliquus) supplements including products labeled as mycelium-fermented-on-grain, Windsor found alpha-glucan content of 33-68% in the fermented grain products and 46-74% in the raw grain substrates.[1] Alpha-glucan is the structural name for starch, the carbohydrate found in grain. Authentic wild chaga canker material measured near-zero for starch content. Beta-glucan content in the grain-grown products measured at roughly 1-5%.

The contrast in absolute numbers is substantial. Authentic chaga is predominantly water, fiber, and bioactive polysaccharides including beta-glucans. Grain-grown chaga supplement products are predominantly starch from the colonized grain, with beta-glucan content at a fraction of what wild material contains.

For Reishi, Wu and colleagues conducted a quality audit of Ganoderma lucidum dietary supplements sold in the US, finding wide variation in quality between products.[2] Products containing myceliated grain material showed significantly lower ganoderic acid content, the triterpenoid class associated with reishi's anti-tumor and adaptogenic properties, compared to fruiting body extracts. Polysaccharide content also varied dramatically. Some products that appeared similar on the label contained compound profiles that differed by orders of magnitude.

The pattern across both studies: when mycelium-on-grain products appear alongside authentic fruiting body material in direct analytical comparison, the grain-grown products consistently measure lower for the compounds that define therapeutic activity and higher for grain-derived starch.

The Label Loophole: Why 'Polysaccharides' Misleads

The measurement gap between beta-glucans and total polysaccharides is the labeling problem that allows high-starch products to claim high polysaccharide content.

Polysaccharides are long-chain sugar molecules. Beta-glucans are polysaccharides with beta-1,3 and beta-1,6 glucose linkages that form the structural backbone of mushroom cell walls and drive immune activation. Alpha-glucans are polysaccharides with alpha-1,4 linkages. That's the chemical structure of starch. When a supplement label reports "polysaccharides," it reports the sum of both types. A product that is 60% grain starch and 5% beta-glucan can report 65% polysaccharides.

Timm and colleagues, in their 2023 review of mushroom beta-glucan research and applications, identified the need for standardized testing methods that measure beta-glucans specifically rather than total polysaccharides.[7] The Megazyme enzymatic assay is the most widely used testing method for distinguishing beta-glucans from alpha-glucans in mushroom products. It uses specific enzymes to sequentially break down and measure alpha- and beta-glucan fractions. But even the Megazyme test is imperfect: Kanno and colleagues developed a novel antibody-based quantification method and found that the Megazyme enzymatic approach overestimates beta-glucan content in some mushroom species due to cross-reactivity with certain non-glucan polysaccharides.[6]

López-García and colleagues applied a different approach entirely: mass spectrometry analysis (MALDI-TOF) to characterize polysaccharide profiles in commercial mushroom supplement products.[3] The analysis detected starch-derived polysaccharide fragments in grain-grown products. These fragments produce characteristic peaks in the mass spectrum that differ structurally from the beta-glucan chains found in authentic mushroom material. The presence of starch fragments is, in chemical terms, a fingerprint of the grain substrate that survived the colonization and grinding process.

The practical significance of the labeling gap: a consumer reading a supplement label that reports 40% polysaccharides has no way to determine what fraction of that 40% is immune-active beta-glucan and what fraction is grain starch, without access to Megazyme test results or other specific beta-glucan measurements. The polysaccharide number, presented alone, provides no useful information about mushroom bioactive content.

Why Grain-Based Production Persists

Given the composition data, the reasonable question is why grain-based production remains common in the supplement industry. The answer is primarily economic and logistical.

Growing mushroom mycelium on grain is significantly faster and cheaper than producing fruiting bodies. Fruiting body cultivation requires specific humidity, temperature, CO2, and lighting conditions maintained over weeks to months per flush. The final yield of dried fruiting body material per unit of space and time is substantially lower than the yield of myceliated grain per unit of the same inputs. Grain colonization can be completed in 30-60 days under controlled conditions. Fruiting body development requires months and multiple optimized environmental transitions.

For supplement companies working at scale, myceliated grain also produces consistent batch quantities more predictably than fruiting body harvests, which depend on successful pinning and flush development. The grain substrate provides nutrients and structure that support rapid colonization without the precise environmental control that fruiting body development requires.

Nguyen and Ranamukhaarachchi's work on grain substrate effects confirms that different grain types can be selected to optimize mycelial density and colonization rate, allowing producers to tune the process further.[4] The result is a production method that is more predictable, faster, and cheaper per unit of dry weight than fruiting body cultivation.

Wu and colleagues' US supplement audit found that this economic reality is reflected in the market: multiple Reishi products made from myceliated grain were sold at the same price points as fruiting body extracts, without the label clearly distinguishing the production method.[2] When the compounds in the final product measure an order of magnitude lower in therapeutic content, the price-per-dose economics change substantially.

The Cordyceps Exception: Grain Substrates That Produce Fruiting Bodies

Cordyceps militaris is the species most often mischaracterized in the mycelium-on-grain debate, because it occupies a genuinely different category from other mushrooms.

Liang and colleagues tested a range of grain substrates for their effect on Cordyceps militaris fruiting body production and bioactive compound yields.[5] Unlike most edible mushrooms, Cordyceps militaris can be induced to form fruiting bodies directly on grain substrates under appropriate conditions. The study found that substrate composition significantly affects cordycepin and adenosine concentrations in the final material, but the material produced was actual fruiting body tissue, not mycelium remaining in the vegetative phase.

Park's 2025 comprehensive review of culture conditions in Cordyceps militaris confirmed and expanded on this substrate dependence.[8] Temperature, light, CO2 levels, humidity, and substrate grain type all substantially alter cordycepin, adenosine, and polysaccharide yields. A Cordyceps supplement grown on brown rice with optimized lighting and temperature can produce meaningfully different compound profiles than one grown on wheat under ambient light. But critically, if fruiting bodies form on the grain substrate, the product is a fruiting body product, not a mycelium-on-grain product, even if grain substrate residue is present.

The relevant question for Cordyceps supplements is therefore not whether grain was used but whether fruiting bodies formed. Supplements that show visible orange fruiting body stalks in photographs, or that specify "Cordyceps fruiting body cultivated on grain," represent a different product category than mycelium-on-grain. For most other mushroom species, grain-based cultivation does not produce fruiting bodies under commercially realistic conditions, and the mycelium-on-grain critique applies directly.

Identifying Grain-Based Products: What the Research Reveals

The analytical studies in this area provide a clear picture of the signals that distinguish grain-based products from fruiting body material.

Windsor 2025 and Wu 2017 both identified markers that appear consistently in grain-grown products and not in authentic fruiting body material: elevated alpha-glucan content, lower beta-glucan-to-total-polysaccharide ratio, lower concentrations of species-specific secondary metabolites (ganoderic acids in reishi, inotodiol in chaga), and in mass spectrometry, the starch fragment peaks that López-García 2016 documented.[1][2][3]

On supplement labels, grain-based products typically carry one of the following product descriptor terms: "mycelium," "myceliated grain," "myceliated rice," "mushroom mycelium powder," or variations listing a grain and mushroom species together (for example, "Trametes versicolor mycelium on rice"). Products that do not specify a grain substrate and list only "fruiting body extract" or "fruiting body powder" are describing a different production pathway.

The measurement most useful for comparison is a separately reported beta-glucan percentage using the Megazyme method. Timm 2023 and the broader literature consistently identify this as the key discriminating measurement.[7] A product listing only "polysaccharides" without a separate beta-glucan number provides no reliable information about beta-glucan content. Products that provide a Megazyme-tested beta-glucan percentage allow direct comparison to wild or cultivated fruiting body benchmarks.

For the broader question of how substrate composition affects compound profiles, how growing substrate affects mushroom bioactive content examines this across species. For the full analytical chemistry argument about why the beta-glucan/alpha-glucan distinction matters at the mechanistic level, the science behind the fruiting body vs. mycelium argument covers the glucan chemistry in depth. And for understanding what "full spectrum" products claiming both fruiting body and mycelium are actually delivering, full-spectrum mushroom products: fruiting body and mycelium separates marketing from substance.

The Bottom Line

Mycelium on grain is a production method that colonizes grain substrate with mushroom mycelium, then grinds the colonized mass into powder without separating fungal tissue from grain. A 2025 peer-reviewed analysis of real-world chaga supplements found alpha-glucan (grain starch) content of 33-68% in these products, with beta-glucan content at 1-5%. The labeling problem is that supplement labels report "total polysaccharides," a number that combines both beta-glucans and grain starch, making it impossible to assess mushroom bioactive content without a separate beta-glucan measurement. Cordyceps militaris is a notable exception: grain substrates can support actual fruiting body formation in this species, making grain-based Cordyceps products a distinct category from standard mycelium-on-grain supplements.

Frequently Asked Questions

Sources & References

  1. 1RTHM-02209·Windsor, Coleton et al. (2025). “What This 2025 Chaga Supplement Authentication Study Actually Found.” International journal of molecular sciences.Study breakdown →PubMed →↩
  2. 2RTHM-00499·Wu, Ding-Tao et al. (2017). “Evaluation on quality consistency of Ganoderma lucidum dietary supplements collected in the United States..” Scientific reports.Study breakdown →PubMed →↩
  3. 3RTHM-00437·López-García, Marta et al. (2016). “MALDI-TOF to compare polysaccharide profiles from commercial health supplements of different mushroom species..” Food chemistry.Study breakdown →PubMed →↩
  4. 4RTHM-00645·Nguyen, Thanh M et al. (2020). “Effect of Different Culture Media, Grain Sources and Alternate Substrates on the Mycelial Growth of Pleurotus eryngii and Pleurotus ostreatus..” Pakistan journal of biological sciences : PJBS.Study breakdown →PubMed →↩
  5. 5RTHM-00617·Liang, Zeng-Chin et al. (2014). “Various grain substrates for the production of fruiting bodies and bioactive compounds of the medicinal caterpillar mushroom, Cordyceps militaris (Ascomycetes)..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
  6. 6RTHM-00625·Kanno, Takashi et al. (2020). “Quantification of β-Glucan from Culinary-Medicinal Mushrooms Using Novel Artificial β-Glucan Recognition Protein..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
  7. 7RTHM-00854·Timm, Thaynã Gonçalves et al. (2023). “Mushroom β-glucans: application and innovation for food industry and immunotherapy..” Applied microbiology and biotechnology.Study breakdown →PubMed →↩
  8. 8RTHM-02159·Park, Hye-Jin (2025). “Influence of Culture Conditions on Bioactive Compounds in Cordyceps militaris: A Comprehensive Review..” Foods (Basel.Study breakdown →PubMed →↩